Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 861177 NEW YORK, NY
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,185,034
+$1,756,803 QoQ
Shares Held
183,048
+20.7% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 334 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 36% Shared 0% None 64%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. FTRE ranks #85 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in FTRE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,185,034 183,048
2026-03-31 $1,428,231 151,617
2025-12-31 $1,887,615 109,427
2025-06-30 $1,571,219 318,061
2025-03-31 $2,134,986 282,780
2024-12-31 $4,756,381 255,034
2024-09-30 $4,986,860 249,343
2024-06-30 $5,959,004 255,313
2024-03-31 $6,386,513 159,106
2023-12-31 $5,569,550 159,586
2023-09-30 $4,784,762 167,358